Clinical Trial Update: Post-bypass Prophylactic IVIG in Infants and Neonates [NA]

View source ↗

Summary

This clinical trial update reports the results of a completed study evaluating post-bypass prophylactic intravenous immunoglobulin (IVIG) in infants and neonate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Hypogammaglobulinemia

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Hypogammaglobulinemia, Congenital Heart Disease | NA | Status: COMPLETED | Results posted: 2017-04-13